Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
June 28, 2022PLoS ONEOpen Access

Cost-effectiveness analysis of implementing screening on preterm pre-eclampsia at first trimester of pregnancy in Germany and Switzerland

View Full Paper
Ask AI
Bookmark
Share

Authors

JMJanne C. MewesOlympus (Germany)MLMelanie LindenbergThe Netherlands Cancer InstituteHVHubertus JM VrijhoefHeart Failure & Transplant

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Mewes et al. (2022) studied this question.

synapsesocial.com/papers/6a5c48d6974b0f386b56f4dahttps://doi.org/10.1371/journal.pone.0270490
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Pre-eclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta-analysis2007 · 2,575 citations
  2. 2Risk of Fetal Death With Preeclampsia2015 · 132 citations
  3. 3Pre-eclampsia and risk of later kidney disease: nationwide cohort study2019 · 151 citations
  4. 4Accuracy of competing‐risks model in screening for pre‐eclampsia by maternal factors and biomarkers at 11–13 weeks' gestation2017 · 263 citations